SCRC........WAKE UP SHAREHOLDERS NEW PR RELEASE TH
Post# of 7769
Posted On: 04/22/2014 8:34:25 AM
SCRC........WAKE UP SHAREHOLDERS NEW PR RELEASE THIS MORNING!!!.....THIS SHOULD SOLIDIFY THAT ALL HELL IS ABOUT BREAK LOOSE FOR SCRIPSAMERICA MOVING FORWARD > : April 22, 2014 - 8:30 AM EDT
ScripsAmerica's PIMD International Receives DEA License to Distribute Class 2 Through 5 Pharmaceutical Formularies
Pharmaceutical Wholesaler Receives Permission to Receive, Store and Ship Additional Drug Formularies
TYSONS CORNER, Va., April 22, 2014 (GLOBE NEWSWIRE) -- ScripsAmerica, Inc. (OTCBB:SCRC) today announced that PIMD International, LLC has recently received a license to receive, store and ship Schedule 2 through Schedule 5 formulary pharmaceuticals in Florida and Pennsylvania.
PIMD International's new headquarters, located in Doral, Florida, passed the inspection process necessary to receive the licenses for products that are designated as Schedule 2,3,4 and 5 by the DEA. The Company expects PIMD's revenue to grow with the addition of these new formularies and is in the process of expanding its market reach by applying for licensing in additional states.
PIMD International serves as a pharmaceutical wholesaler to pharmacies, hospitals, and physician's offices in the US and provides ScripsAmerica's customers with access to specific medications for its end users. PIMD also sells medical supplies in all healthcare settings and online at www.pimdintl.com.
"We are very excited to receive these pharmaceutical dispersement licenses by the DEA as they expand PIMD's ability to service independent pharmacies in new areas with additional products. We expect these new licenses to generate rapid growth in our prescription revenues and expect to experience growth on all fronts in 2014 which includes sales from our medical supply website as well," stated PIMD International's Founder, Vanessa Gonzalez, PharmD.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.
ScripsAmerica's PIMD International Receives DEA License to Distribute Class 2 Through 5 Pharmaceutical Formularies
Pharmaceutical Wholesaler Receives Permission to Receive, Store and Ship Additional Drug Formularies
TYSONS CORNER, Va., April 22, 2014 (GLOBE NEWSWIRE) -- ScripsAmerica, Inc. (OTCBB:SCRC) today announced that PIMD International, LLC has recently received a license to receive, store and ship Schedule 2 through Schedule 5 formulary pharmaceuticals in Florida and Pennsylvania.
PIMD International's new headquarters, located in Doral, Florida, passed the inspection process necessary to receive the licenses for products that are designated as Schedule 2,3,4 and 5 by the DEA. The Company expects PIMD's revenue to grow with the addition of these new formularies and is in the process of expanding its market reach by applying for licensing in additional states.
PIMD International serves as a pharmaceutical wholesaler to pharmacies, hospitals, and physician's offices in the US and provides ScripsAmerica's customers with access to specific medications for its end users. PIMD also sells medical supplies in all healthcare settings and online at www.pimdintl.com.
"We are very excited to receive these pharmaceutical dispersement licenses by the DEA as they expand PIMD's ability to service independent pharmacies in new areas with additional products. We expect these new licenses to generate rapid growth in our prescription revenues and expect to experience growth on all fronts in 2014 which includes sales from our medical supply website as well," stated PIMD International's Founder, Vanessa Gonzalez, PharmD.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.
(0)
(0)